PRCT - NASDAQ

PROCEPT BioRobotics Corporation

PRCT·NASDAQ

$26.33

-1.6%

HealthcareMedical - Devices

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.50B

EPS-1.7200

P/E Ratio-15.31

Earnings Date08/05/2026

prct

Net Receivables

Last Annual Value

83.53M

3-Year CAGR

76%

5-Year CAGR

122%

10-Year CAGR

54%

Adjust for Inflation

PROCEPT BioRobotics Corporation Competitors Analysis of Net Receivables

PRCT · NASDAQ

Company	Net Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
PROCEPT BioRobotics Corporation NASDAQ:PRCT	83.53M	20.0%	79.6%	N/A
SS Innovations International, Inc. NASDAQ:SSII	12.40M	96.0%	N/A	N/A
Guardian Pharmacy Services, Inc. NYSE:GRDN	101.61M	9.6%	13.0%	N/A
QuidelOrtho Corporation NASDAQ:QDEL	417.00M	-5.1%	1.2%	32.5%
Twist Bioscience Corporation NASDAQ:TWST	57.02M	9.0%	14.8%	54.8%
Edgewise Therapeutics, Inc. NASDAQ:EWTX	0.00	N/A	N/A	N/A
Artivion, Inc. NYSE:AORT	103.68M	11.8%	12.3%	13.2%
Clover Health Investments, Corp. NASDAQ:CLOV	158.74M	22.6%	7.7%	N/A
Inspire Medical Systems, Inc. NYSE:INSP	119.69M	10.0%	28.5%	49.9%

PROCEPT BioRobotics Corporation Fair Value Envelope

PRCT · NASDAQ

Our analysis suggests that PRCT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $26.33, this represents a potential HIDDEN relative to our calculated worth for PROCEPT BioRobotics Corporation.

HIDDEN

Intrinsic Value

Current Price: $26.33

Related Guides

Blog Categories

Continue your PRCT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.